Infinity Pharmaceuticals reported $-10874000 in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amgen AMGN:US USD 3.65B 1.23B
AstraZeneca AZN:LN USD 35.13B 798M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Cytori Therapeutics CYTX:US USD 11.4M 1.72M
Eisai 4523:JP JPY 828.13B 23.58B
Eli Lilly And LLY:US USD 10.07B 1.53B
Genocea Biosciences GNCA:US USD 12.38M 14.69M
Gilead Sciences GILD:US USD 21.06B 821M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Infinity Pharmaceuticals INFI:US USD -10874000 9.77M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Novartis NOVN:VX USD 60.82B 2.1B
Roche Holding ROG:VX 25.19B 700M
Seattle Genetics SGEN:US USD 2.82B 111M
Tg Therapeutics TGTX:US USD 100.48M 28.55M
Vascular Biogenics VBLT:US USD 25.3M 9.07M
YTE INCY:US USD 4.23B 141.59M